Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Update: A Pemex subsidiary completed the deal with former 50-50 joint venture partner Shell PLC subsidiary Shell Oil Co. to acquire full ownership of Shell Deer Park Refining LP’s 340,000-b/d refinery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results